2
Views
2
CrossRef citations to date
0
Altmetric
Original Article

The Determination of Fibrinolytic Degradation Products in Concentrated Urine After Renal Transplantation

, , &
Pages 56-62 | Received 18 Dec 1974, Published online: 15 Feb 2010

REFERENCES

  • Andersson, L. 1962. Treatment of so-called essential haematuria with fibrinolytic inhibitor (epsilon-aminocaproic acid). Acta Chir Scand 124, 355.
  • Antoine, B., Neveu, T. & Ward, P. D. 1969. Fibrinuria during renal transplantation. Transplantation 8, 98.
  • Bettex-Galland, M., Lüschner, E. F., Simon, G. & Vassalli, P. 1963. Introduction of viscous metamorphosis in human blood platelets by means other than thrombin. Nature 200, 1109.
  • Bouma, B. N., Hedner, U. & Nilsson, I. M. 1971. Typing of fibrinogen degradation products in various clinical disorders. Scand J Clin Lab Invest 27, 331.
  • Braun, W. E. & Merrill, J. P. 1968. Urine fibrinogen fragments in human renal allografts. New Engl J Med 278, 1366.
  • Busch, G. J., Braun, W. E., Carpenter, C. B., Corson, J. M., Galvanek, E. R., Reynolds, E. S., Merrill, J. P. & Dammin, G. J. 1969. Intravascular coagulation in human renal allograft rejection. Transpl Proc 1, 267.
  • Carlsson, S., Hedner, U., Nilsson, I. M., Bergentz, S. E. & Ljungqvist, U. 1970. Kidney transplantation and fibrinolytic split products in serum and urine. Transplantation 5, 336.
  • Claes, C. E. & Svalander, C. 1972. Studies on platelets and fibrin during rejection of canine renal allograft. Scand J Urol Nephrol Suppl. 10.
  • Clarkson, A. R., Morton, J. B. & Cash, J. D. 1970. Urinary fibrin/fibrinogen degradation products after renal transplantation. Lancet II, 1220.
  • Clarkson, A. R., MacDonald, M. K., Petrie, J. J. B., Cash, J. D. & Robson, J. S. 1971. Serum and urinary fibrin/fibrinogen degradation products in glomerulonephritis. Br Med J III, 447.
  • Dempster, W. J. 1953. Kidney homotransplantation. Br J Surg 40, 447.
  • Ekert, H., Barratt, I. M., Chantler, C. & Turner, M. W. 1972. Immunologically reactive equivalents of fibrinogen in sera and urine of children with renal disease. Arch Dis Child 47, 90.
  • Hedner, U. & Nilsson, I. M. 1971. Clinical experience with determination of fibrinogen degradation products. Acta Med Scand 189, 471.
  • Hedner, U., Ekberg, M. & Nilsson, I. M. 1974. Urinary fibrin/fibrinogen degradation products (FDP) and glomerulonephritis. Acta Med Scand 195, 81.
  • Hume, D. M. & Engdahl, R. H. 1955. Progressive destruction of renal homografts isolated from the regional lymphatics of the host. Surgery 38, 194.
  • Laurell, C. B. 1966. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15, 45.
  • Mowbray, J. F. 1966. Methods of suppression of immune response. Excerpta Med Int Congr Series 137, 106.
  • Naish, P., Peters, D. K. & Shackman, R. 1973. Increased urinary fibrinogen derivatives after renal transplantation. Lancet I, 1280.
  • Niléhn, J. E. 1967. Split products of fibrinogen after prolonged interaction with plasmin. Thrombos Diathes Haemorrh (Stuttg) 18, 89.
  • Pandolfi, M., Bergentz, S. E., Claes, G. & Ljungqvist, U. 1971. Localisation of fibrinolytic activity in healthy and diseased renal tissue. Microcirculatory approaches to current therapeutic problems. 6th European Conf. on Microcirculation, Aalborg, p. 88. Karger, Basel.
  • Paraskevas, M., Nilsson, I. M. & Martinsson, G. 1962. A method for determining serum inhibitors of plasminogen activities. Scand J Clin Lab Invest 14, 138.
  • Vermylen, J., Dotremont, G., Donati, M. B., Molla, A. & Michelsen, P. 1972. Urinary excretion of fibrinogen-fibrin related antigen in glomerulonephritis, effect of Indomethacin. III Congr Int Soc Thromb Haemostasis, Washington, D.C.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.